Fundraising Fox

Elucidata

Cambridge, US · Founded 2017 · Delaware corporation · 4 known investors

Elucidata is a company oriented around supporting scientific research, emphasizing making users' research more efficient and respecting the scientific method. The available page content does not describe its concrete products or offerings in detail.

AI & Machine LearningBiotechData & Infrastructure

Founders & leadership

Elucidata was founded in 2017 by Abhishek Jha and Swetabh Pathak.

AJAbhishek Jha
Abhishek JhaCo-founder & CEO
SP
Swetabh PathakCo-founder

Investors · 4

Hyperplane Venture Capital✓ verifiedBoston · $250K – $3M
Eight Roads Ventures✓ verifiedMumbai · $5M – $30M
IvyCap Ventures✓ verifiedMumbai · $300K – $33M
F-Prime CapitalCambridge · $3M – $10M

Reported raises · per SEC filings

Form D private placements

$2.6M disclosed across 2 rounds · 2018–2020

▶$880KraisedJul 2020 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Abhishek JhaExecutive Officer, Director
  • Swetabh PathakDirector
Offering amount
$1.5M
Amount sold
$880K
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.7MraisedMay 2018 · 16 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Abhishek JhaExecutive Officer, Director
  • Swetabh PathakDirector
Offering amount
$1.7M
Amount sold
$1.7M
First sale
May 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap
Oup200 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
IDbyDNA155 shared keywordsScalable, high throughput DNA sequencing platforms.
10x Genomics 1-color137 shared keywords10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.

Companies competing with Elucidata for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Elucidata Raises $16 Million Series A to Reimagine AI Infrastructure for the Life Sciences Industryprnewswire.com · Sep 2022Elucidata Raises $16M in Series A Funding - FinSMEsfinsmes.com · Sep 2022Mybigplungemybigplunge.com · Jan 2021Elucidata Raises Seed Funding to Transform Drug Discovery and Accelerate Growth | Elucidata | by Elucidata | Elucidata | Mediummedium.com · Jul 2020Elucidata Raises $1.7M in Seed Funding - FinSMEsfinsmes.com · Jun 2018Elucidata Raises Seed Funding to Transform Drug Discovery and Accelerate Growth | Business Wirebusinesswire.com · Jun 2018

Frequently asked questions

What does Elucidata do?
Elucidata is a company oriented around supporting scientific research, emphasizing making users' research more efficient and respecting the scientific method. The available page content does not describe its concrete products or offerings in detail.
Who founded Elucidata?
Elucidata was founded by Abhishek Jha, Swetabh Pathak in 2017.
Who are Elucidata's investors?
Elucidata's investors include Hyperplane Venture Capital, Eight Roads Ventures, IvyCap Ventures, F-Prime Capital.
How much funding has Elucidata raised?
Elucidata has disclosed $2.6M raised across 2 rounds.
Where is Elucidata headquartered?
Elucidata is headquartered in Cambridge, US.